Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Sarcoma and GIST Cancer Translational Research Disease Group
Understanding the genetic alterations that lead to sarcoma and GIST cancer is essential to fighting the disease. At Fox Chase, a multidisciplinary team of researchers and clinicians meets regularly to review translational research initiatives to identify and characterize new biomarkers of sarcoma and GIST cancers that lead to new, innovative prevention and targeted therapy options for our patients.
Faculty Group Members
- Suzanne Beers, Director of Development, Institutional Advancment
- Martin Belinsky
Clinical and research fellows are welcome to attend this TRDG meeting. Also, any faculty who have an interest in participation please communicate with Alison Conn.
Support for our research initiatives allows Fox Chase to have a continued stake in the future of translational research, and the Center encourages our researchers and clinician to apply for grant funding to advance the mission to prevail over cancer. Below is a list of current research funding opportunities: